Oruka Therapeutics, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Oruka Therapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Oruka Therapeutics, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $23K, a 30.3% decline year-over-year.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2023 was $127K, a 3.05% decline from 2022.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2022 was $131K, a 56% increase from 2021.
  • Oruka Therapeutics, Inc. annual Operating Lease, Payments for 2021 was $84K, unchanged from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $23K -$10K -30.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q1 2023 $33K +$1K +3.13% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q1 2022 $32K +$25K +357% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-24
Q1 2021 $7K -$18K -72% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-02
Q1 2020 $25K +$2K +8.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q1 2019 $23K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.